These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies. Jean M; Smaoui F; Lavertu M; Méthot S; Bouhdoud L; Buschmann MD; Merzouki A Gene Ther; 2009 Sep; 16(9):1097-110. PubMed ID: 19440230 [TBL] [Abstract][Full Text] [Related]
7. Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. Rutherford C; Martin W; Salame M; Carrier M; Anggård E; Ferns G Atherosclerosis; 1997 Apr; 130(1-2):45-51. PubMed ID: 9126647 [TBL] [Abstract][Full Text] [Related]
8. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. Nissen LJ; Cao R; Hedlund EM; Wang Z; Zhao X; Wetterskog D; Funa K; Bråkenhielm E; Cao Y J Clin Invest; 2007 Oct; 117(10):2766-77. PubMed ID: 17909625 [TBL] [Abstract][Full Text] [Related]
9. Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells. Faraone D; Aguzzi MS; Ragone G; Russo K; Capogrossi MC; Facchiano A Blood; 2006 Mar; 107(5):1896-902. PubMed ID: 16322476 [TBL] [Abstract][Full Text] [Related]
10. Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts. Tokuda H; Takai S; Hanai Y; Harada A; Matsushima-Nishiwaki R; Kato H; Ogura S; Kozawa O J Bone Miner Metab; 2008; 26(4):335-41. PubMed ID: 18600399 [TBL] [Abstract][Full Text] [Related]
11. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis. Bai Y; Bai L; Zhou J; Chen H; Zhang L Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157 [TBL] [Abstract][Full Text] [Related]
12. R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. Cao Y; Cao R; Hedlund EM J Mol Med (Berl); 2008 Jul; 86(7):785-9. PubMed ID: 18392794 [TBL] [Abstract][Full Text] [Related]
13. Low plasma levels of FGF-2 and PDGF-BB are associated with cardiovascular events in type II diabetes mellitus (diabetes heart study). Yeboah J; Sane DC; Crouse JR; Herrington DM; Bowden DW Dis Markers; 2007; 23(3):173-8. PubMed ID: 17473387 [TBL] [Abstract][Full Text] [Related]
14. Role of VEGF family members and receptors in coronary vessel formation. Tomanek RJ; Holifield JS; Reiter RS; Sandra A; Lin JJ Dev Dyn; 2002 Nov; 225(3):233-40. PubMed ID: 12412005 [TBL] [Abstract][Full Text] [Related]
16. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Kohno M; Yokokawa K; Yasunari K; Minami M; Kano H; Hanehira T; Yoshikawa J Circulation; 1998 Jul; 98(4):353-9. PubMed ID: 9711941 [TBL] [Abstract][Full Text] [Related]
17. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling. Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906 [TBL] [Abstract][Full Text] [Related]
18. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. Battegay EJ; Rupp J; Iruela-Arispe L; Sage EH; Pech M J Cell Biol; 1994 May; 125(4):917-28. PubMed ID: 7514607 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model. Li J; Wei Y; Liu K; Yuan C; Tang Y; Quan Q; Chen P; Wang W; Hu H; Yang L Microvasc Res; 2010 Jul; 80(1):10-7. PubMed ID: 20045007 [TBL] [Abstract][Full Text] [Related]
20. The effect of locally administered anti-growth factor antibodies on neointimal hyperplasia formation in expanded polytetrafluoroethylene grafts. Sapienza P; di Marzo L; Cucina A; Borrelli V; Mosiello G; Basile U; Iacovitti S; Cavallaro A Ann Vasc Surg; 2009; 23(3):398-409. PubMed ID: 19427566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]